of the spine and pain in the temporomandibular joints. Subsequently, the feet, knees, and ankles were involved. The rash on her face spread and became more erythematous. Diagnoses of Still's disease and discoid lupus erythematosus were made.
Treatment with cortisone abolished the fever;
From the U. S. Department of Health, Education, and Welfare, U.S. Public Health Service, Bethesda, Md. the joint symptoms and the rash subsided but did not entirely disappear. Facial rounding and edema developed, but the dose of cortisone could not be lowered below 200 mg./day without return of joint pain and some fever. This regimen was continued for 2 years, when hydrocortisone was substituted in a minimum maintenance dose of 60 mg./day. Because of persistent activity of the disease process, an L.E. cell preparation was done, but was negative.
The patient was referred to the Clinical Center for treatment with the new steroids. Her past history was negative except for measles at age 4 and varicella at age 5. There was no family history of arthritis or related diseases.
On examination at the time of admission, the patient was a very small, thin, alert white girl in no discomfort, but coughing occasionally. The blood pressure was 110/70 mm. Hg, temperature 98.7 F., pulse 110. There was an erythematous rash on the left cheek and left elbow that was slightly raised and indurated and showed dilated follicular pores, follicular keratoses, and some central atrophy. Small acneform lesions were also present on the face. A rough, reddened patch was present on the hard palate. Small cervical, axillary, and inguinal nodes were palpable. No retinopathy was noted. Moist rales were heard over the right middle lobe. The heart was negative, the liver and spleen were not palpable, and there was no swelling or tenderness of any joint. There was clubbing of the fingers with dystrophic and hypertrophic nail changes ( fig. 1 4.4 Gm. per cent, and bilirubin 0.4 and uric acid 2.3 mg. per cent. Roentgenograms revealed areas of fibrosis and reticular mottling in both lung fields, some delay in bone development, and negative gastrointestinal tract. Electrocardiogram was normal.
It was thought that the patient had developed systemic lupus erythematosus. The L.E. preparation had been negative in the past, but after 2 negative tests, 3 subsequent smears were positive. The pulmonary findings could be part of systemic lupus or could be related to chronic pulmonary infection following the episode of pneumonia in infancy.
Following initial observations, the dose of hydrocortisone was lowered. At a level of 30 mg./day she developed indurated, erythematous, slightly tender areas about both elbows. At 10 mg./day the manifestations of lupus flared up, with fever to 100.7 F., marked malaise, severe anorexia, and diffuse aches and pains that were most marked in the joints. The facial rash spread, and a 0.5 cm. superficial ulceration appeared in the right buccal mucosa. The cough increased in severity, and fine, moist rales were heard throughout both lung fields. Tenderness was noted over all joints with swelling about the elbows. The sedimentation rate rose to 88 mm./hr. (Westergren), and the C-reactive protein became 1 +. The hydrocortisone was abruptly discontinued, and prednisone, 20 mg./day, was given. There was dramatic improvement, with an abrupt end to the fever, malaise, pain, and anorexia. The joint tenderness subsided, the rates diminished, and the facial rash and mucous membrane lesions gradually faded. The dose of prednisone was subsequently lowered to 15 mg. daily, and the patient continued to do well. She has become completely asymptomatic and remains well at this time.
Dr. T. F. Hilbish: This patient has small, reticular infiltrative lesions throughout both lung fields, most marked in the lower lobes and particularly on the left. The lung fields show very small linear bands of fibrosis. The heart is within the upper limits of normal.
The only other radiologic finding is retardation in bony development. Practically all the joints that were x-rayed showed some delay in bony growth. For example, the head of the radius is very small and undeveloped for the patient's age. X-rays of the bones in hands and feet also show developmental retardation.
Dr. Bunim: There are several points in this patient's story that are worthy of comment. First, how soon could the diagnosis of lupus erythematosus have been made from the clinical features?
She started with a pulmonary infection that was considered to be pneumonia and was treated with penicillin. This was soon followed by an erythematous rash. We have no direct information on this earlier infection, but we do have some notes from the physician who saw her at the age of 2 years and 9 months for a recurrence of pulmonary infection.
According to these notes, there were dullness and bronchial breathing over the left lobe of the lung posteriorly. A presumptive diagnosis of pulmonary tuberculosis was supported by a positive patch test, later shown to be a false positive reaction. X-ray of the chest showed enlargement of both hilar regions and numerous areas of infiltration in both lung fields, especially the left. The spleen was palpable 3 fingerbreadths below the costal margin, the white count was 5,200, and the sedimentation rate was markedly elevated. Within 14 days after this examination the patient developed polyarthritis, which persisted for several years. Even with 60 Gm. of hydrocortisone, this child continued to have active disease, for which she was referred to the Clinical Center. Now she is completely symptom-free at 15 mg. of prednisone daily, a 4:1 ratio, but the control is maximum rather than barely satisfactory. It remains to be seen whether she will require more prednisone when she goes home and becomes more active.
Finally, I would like to discuss the question of transition from discoid lupus to systemic lupus erythematosus. The impression that discoid lupus does not go on to systemic lupus is not true. As early as 1937, Dr. Keil of New York noted a transition from the discoid to the systemic type, with clinical and histopathologic confirmation. In our own limited experience we have seen 6 such patients; the interval from the appearance of discoid to systemic lupus ranged from 2 to 31 years. In Dr. Harvey's series there were 3 such patients. Patients with a discoid lesion should therefore be followed very carefully as potential cases of systemic lupus.
If a patient has both systemic lupus erythematosus and an intercurrent infection like pneumonia and is treated with antibiotics alone without concomitant adrenal cortical steroids of some type, he may succumb. Consequently, it is extremely important to keep patients with discoid lupus under surveillance and to administer steroid therapy at the first sign of severe systemic involvement.
Dr. Eugene Van Scott: Lupus erythematosus was first described, roughly 125 years ago, when medicine was largely a descriptive science. The definitive descriptions of the gross, and later microscopic, characteristics of the skin lesions are examples of astute, detailed obser-vations. The disease was first recognized as a primary skin disease, manifested by chronic patches of scaling erythema that often eventuated into scarring and atrophy of the involved skin. About 50 years later the disseminated form of the disease was described. It was noted that a certain number of individuals with skin lesions acquired a serious systemic illness.
Without precise figures, I think we can reasonably agree that the chronic discoid form tends to remain confined to the skin, with a very small percentage eventuating in the systemic disease. Whether to stress and study the similarities of these two states and their transitions or to stress and study their differences is perhaps of more than theoretic interest; the current tendency is to study the similarities. An important clue to the more serious systemic illness may lie in the fact that so many chronic discoid cases never disseminate.
One particular phenomenon found in this condition, ultraviolet sensitivity, is important at least in stimulating further thought. It is common knowledge that exposure to sunlight has a pronounced adverse effect on patients with either systemic or localized cutaneous lupus erythematosus. Indeed, some subjects without L.E. develop skin eruptions from sunlight, and microscopically the lesions are indistinguishable from L.E. One of the effects of ultraviolet light in suberythema general body exposures is to produce a picture that resembles adrenal insufficiency. These effects include a fall in blood pressure lasting 24 hours, a low fasting blood sugar, a flat glucose tolerance curve, and an increased readiness to skin pigmentation. Is this observation related to why L.E. is made worse by ultraviolet light and is improved by adrenal steroid therapy?
Second, light sensitivity is pronounced in pellagra, in which the chronic skin eruption grossly and microscopically often resembles lupus erythematosus. We know that this photosensitivity is related to a nicotinic acid deficiency. The classic corn diet possesses a pyridine-containing antagonist of nicotinic acid. Sulfapyridine is also a competitor of nicotinic acid, and the sulfa drugs as a group are capable of inciting or exacerbating cases of L.E., and of photosensitizing normal skin.
From this chain of relationships arises the obvious question whether L.E. is related to defective metabolism of nicotinic acid or tryptophane, a normal precursor of nicotinic acid. Would some related compound be useful in the treatment of lupus erythematosus?
Third, it has been shown that ultraviolet light causes loss of specific absorption spectra of purines and pyrimidines, and depolymerizes desoxyribose nucleic acid. Very probably a depolymerization of DNA occurs in L.E., accounts for some histologic changes in several tissues, and is also a biochemical prerequisite for the L.E. phenomenon and the L.E. cell.
Several phenomena, then, suggest that the metabolism of nicotinic acid, nucleic acids, and the function of the adrenal cortex may be somehow interrelated in the biochemical pathology of lupus erythematosus.
Dr. Naomi Kanof: I would like to discuss 2 aspects of this disease in the patient presented. One concerns the nail changes. I have never seen a patient whose disease onset was as early as in this child, and I am therefore not able to recall changes of similar nature. But in adult patients this bulbous distortion of the fingers is not uncommon, and is an unfavorable prognostic sign, suggesting an acute process.
Every internist and dermatologist who is concerned with this disease comes to a very firm conclusion regarding its evolution and then has an experience to shake his conclusion. One patient mentioned by Dr. Bunim was undeniably a case of chronic discoid lupus erythematosus. But the fact that the child was only 9 years old seemed noteworthy. volved. Not infrequently the pathologist is unable to detect appreciable changes in patients who have had the most profound clinical symptoms. Probably the most characteristic lesions are observed in the circulatory system the heart, small arteries, arterioles, and glomerular capillaries. For purposes of simplification, the vascular lesions may be placed in 2 categories, the luminal and the mural, and they may be illustrated in the renal glomerulus.
The luminal change is characterized by formatioii of hyaline thrombi in some of the capillaries of the tuft. At one time, these thrombi were regarded as an extrusion of a mural deposit into the lumeni. More recently, it, has been recogiiized that the thrombi may be quite discrete ( fig. 2 ) and o(cUIr independently of the so-called wireloop change in the walls of the capillaries ( fig. 3 ). rphe hyaline material appears similar to fibrini and, for this reason, it is often referred to as a fibrinoid substance. A unique feature of the fibrinioi(l material ini disseminiated lupus erythematosus has beeni described recently by Dr. Kleinperer and his associates in New York City as an inc(lusioni of homogeneous material that is stained soiinww-hat blue by hematoxylin. According to these investigators, this "hematoxylin body" is derived from degraded cell nuclei; the desoxyribonucleoprotein becomes depolymerized progressively and is transformed, thereby, into the fibrinoid substance. The hematoxylin body corresponds to the central inclusion of the L.E. cell. When present, the body is regarded as a specific and characteristic feature of disseminated lupus erythematosus.
The mural change is characterized by the deposition of a fibrinoid substance in the wall of the capillaries and other vessels. Similar material may also be seen, at times, in extravascular connective tissues as well. The appearance of chronic lesions, particularly on the face, for many years before any other manifestations of the disease appear, has been discussed today. Also, we have seen patients who had arthritis for many, many years before they developed other manifestations of the disease. One may observe patients in whom the disease apparently began with a hemolytic type of anemia or thrombocytopenic purpura or repeated epileptiform convulsions as the only clinical evidence of illness for as long as 10 or 12 years.
Remissions may last a long time and may vary in degree. The disease may go from a state of fulminating intensity to a period in which the patient is entirely free of any symptom for a long time.
We believe that this is probably a more common disease than any of us realize even now, and that it may go on for many years in a very mild relapsing course. An example is a patient who came into the hospital recently for treatment of severe hypertension. She had never had any complaints concerning her skin or any difficulty other than the hypertension, which developed following pregnancy. The intern who saw this patient knew that she was going to receive hypotensive drugs, one of which is accompanied at times by a rheumaticlike picture, occasionally with the finding of L.E. cells. He saw a very small erythematous lesion on the patient's forehead and ordered an L.E. cell test, which was positive.
Often the manifestations in the beginning are so vague that it is hard to date their onset. When a given manifestation appears, it is natural to make the diagnosis referable to that single organ system. As Dr. Bunim has already stated, many of these patients in the beginning are said to have rheumatoid arthritis.
Many physicians dismiss the possibility of systemic lupus erythematosus unless all the classical manifestations are present in a single period of activity of the disease, but we have seen patients who developed a skin lesion in the beginning and had cutaneous lesions for 10 or 12 years before they developed any other manifestations. Some patients had other manifestations for 10 or 12 years before they ever had any cutaneous lesions, and still other patients ran the full course of the disease without cutaneous manifestations at any time.
It is important, I think, to recognize the minor phases of the illness. For instance, the patient may say that he has always been sensitive to sunlight, or that all of his life he has had recurrent aches in his joints, although they were never severe enough to warrant consulting a physician. The patient may fail to describe a previous attack of pleurisy or a previous episode of cutaneous difficulty unless specifically asked about it because he does not recognize its possible relation to the current complaint.
The clinical diagnosis of systemic lupus, I think, can be made consistently only when the observer appreciates the chronic course of this disease, with episodic periods of illness that may seem entirely unrelated; and that with a disease apparently involving only a single system, such as arthritis, it is important to inquire specifically about previous illnesses that may be related. What has happened in the past may make the current event more meaningful. Figure 4 shows the sex, race, and age incidence at onset in a number of patients that we have observed. I would like to call your attention to 2 points: most of the patients are females, and in most of them the disease begins in the second, third, or fourth decades. One tends to think of skin lesions in relation to this disease as being those that are classically described, but the skin lesions are multiform. Almost any type of lesion may be seen. One thing that has impressed us greatly is the frequency of urticarial lesions and also of lesions resembling angioneurotic edema.
Reference has been made to pulmonary lesions. Dr. Hilbish described the common type of lesion, usually in the lower lung fields. Pulmonary changes are more frequent than has been commonly recognized. They may be chronic in nature. The symptoms of pulmonary difficulty are out of proportion to any objective findings on physical examination. The patient may be tachypneic, dyspneic, somewhat cyanotic, while on examination of the lungs only a few scattered rales may be heard. In going over all our films on these patients, we were impressed with the frequency of elevation of the diaphragm and plate-like areas of atelectasis in the lower portions of the lung fields.
Retinal cytoid bodies are commonly seen. They are exudative lesions in the nerve fiber layer of the retina that resemble cells microscopically. They are not specific for lupus. They have the same appearance as the cotton wool exudates in hypertensive disease and diabetic retinitis.
The Figure 5 shows a survivorship curve that was constructed by Dr. Merrill of the Department of Biostatistics. The duration of disease in these patients was considered from the time the diagnosis was made, not the time of the first manifestation of illness.
In the first 3 months after diagnosis, 13 per cent of the patients died, but after that there has been a rather steady curve, which indicates that about 10 per cent of the original group have died each succeeding year. That leaves 52 per cent of these patients surviving a full 4 years after the diagnosis was made.
Dr. Ragan and his co-workers published an analysis of prognosis several years ago in which 38 per cent survived for 4 years from the time of onset of the first symptom until death. This 4-year survival of 38 per cent is considerably less than in our series; and ours is weighted in the opposite direction, since duration of life was calculated from date of diagnosis. Figure 6 shows the intervals of time from time of onset to time of diagnosis of the disease, illustrating again the chronic nature of this disease. Many of these patients had manifestations for 5, 10, or 15 years before the diagnosis was finally established.
